Science
DeepBAR: AI-Based Technique That May Speed Drug Discovery – Genetic Engineering & Biotechnology News
DeepBAR is a new technique that combines chemistry and machine learning to speed up calculations of drug molecules’ binding affinity to proteins.
A new technique, DeepBAR, quickly calculates the binding affinities between drug candidates and their targets. The approach, which combines chemistry and machine learning, could lower a hurdle in the drug discovery process. DeepBAR yields precise calculations in a fraction of the time compared to previous state-of-the-art methods. The inventors say DeepBAR could one day quicken the pace of drug discovery and protein engineering.
“Our method is orders of magnitude faster than before, meaning we can…
-
General10 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News22 hours agoResilience features in Sunshine Coast Open House
-
Noosa News16 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Business18 hours agoBell Potter names the best ASX shares to buy in October